Damora Therapeutics

WALTHAM, Massachusetts, August 5, 2026 Damora Therapeutics, Inc. announced the initiation of the global Phase 1/1b CLARITY-101 clinical trial...

WALTHAM, Mass., Aug. 5, 2026 Damora Therapeutics, Inc. has announced the initiation of the global Phase 1/1b CLARITY-101 clinical...